Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
10%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
BBH
27
HOLDINGS
13%
ALSO IN IBRN
IBRN
60
HOLDINGS
8%
ALSO IN BBH
SECTOR DRIFT (BBH minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ARGENX SE ADR | 5.0% | 3.7% | 3.7% |
 |
BIOGEN IDEC INC | 3.6% | 3.9% | 3.6% |
|
NEUROCRINE BIOSCIENCES INC | 2.4% | 3.4% | 2.4% |
BBH Overweight Relative to IBRN
|
AMGEN INC | 12.6% |
|
GILEAD SCIENCES INC | 11.6% |
|
VERTEX PHARMACEUTICALS INC | 9.5% |
|
REGENERON PHARMACEUTICALS | 5.8% |
|
INSMED INC | 5.3% |
|
NATERA INC | 5.2% |
|
IQVIA HOLDINGS INC | 4.7% |
|
BEIGENE LTD. SPONSORED ADR | 3.8% |
|
ALNYLAM PHARMACEUTICALS INC | 3.7% |
|
UNITED THERAPEUTICS CORP | 3.7% |
BBH Underweight Relative to IBRN
|
SCHOLAR ROCK HOLDING CORP. | -4.7% |
|
PTC THERAPEUTICS INC | -4.2% |
|
AXSOME THERAPEUTICS, INC. | -3.8% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.5% |
|
ACADIA PHARMACEUTICALS INC | -3.4% |
|
SUPERNUS PHARMACEUTICALS INC | -3.3% |
|
DENALI THERAPEUTICS INC. | -3.1% |
 |
ALKERMES PLC | -3.0% |
|
DYNE THERAPEUTICS INC | -2.9% |